PlainPharmaWatch

CMS Open Payments · Tool

Buxton Biomedical vs Orthopedic Sciences, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Buxton Biomedical has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 8,905, versus 3,369 for the other company. Its single largest recorded recipient represents 94.3% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Buxton Biomedical
HHI 8,905 · top recipient 94.3%
Ranked #177 of 1,838 companies by HHI
Orthopedic Sciences, Inc.
HHI 3,369 · top recipient 38.2%
Ranked #521 of 1,838 companies by HHI

Payment Overview

Company A

Buxton Biomedical

Total Payments
$3.9K
% of Industry
0.0%
Transactions
3
Avg per Transaction
$1.3K
Recipients
3
Avg per Recipient
$1.3K
Payment Types
1
Top Payment Type
Royalty or License
Total Payments
$4.0K
% of Industry
0.0%
Transactions
3
Avg per Transaction
$1.3K
Recipients
3
Avg per Recipient
$1.3K
Payment Types
1
Top Payment Type
Travel and Lodging

Highlighted values indicate the higher figure for each metric.

Total payments compared

Buxton Biomedical vs Orthopedic Sciences, Inc. - total reported payments in CMS Open Payments PY2024

Orthopedic Sciences, Inc.$4.0KBuxton Biomedical$3.9K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Buxton Biomedical

Royalty or License $3.9K

100.0%

Orthopedic Sciences, Inc.

Travel and Lodging $4.0K

100.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Buxton Biomedical

  1. 1

    RAYMOND WURAPA

    $3,675.80 · 1 txns

  2. 2

    MICHAEL R. REDLER

    $118.58 · 1 txns

  3. 3

    OMAR OSMANI

    $104.50 · 1 txns

Orthopedic Sciences, Inc.

  1. 1

    SHOMARI ANDRE RUFFIN

    $1,515.26 · 1 txns

  2. 2

    DAVID WEINER

    $1,254.26 · 1 txns

  3. 3

    Jonathan Anthony Hoskins

    $1,201.29 · 1 txns

Summary Comparison

Metric Buxton Biomedical Orthopedic Sciences, Inc.
Total Payments $3.9K $4.0K
% of Industry Total 0.0% 0.0%
Transaction Count 3 3
Avg per Transaction $1.3K $1.3K
Recipient Count 3 3
Avg per Recipient $1.3K $1.3K
Payment Type Count 1 1
Top Payment Type Royalty or License Travel and Lodging

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.